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EVALUATION OF CUTIMED® SORBACT®:
CLINICAL CASE STUDIES
Introduction
Chronic wounds are characterised by a high bacterial count, the presence of 
more than one bacterial strain, the increased tendency to harbour drug-resistant 
organisms and the presence of biofilms (Vowden et al, 2008).  This can delay 
wound healing and make these wounds difficult for nurses to manage.  Cutimed 
Sorbact dressings irreversibly bind bacteria and fungi and offer an alternative 
approach to the management of bioburden (Hampton, 2007; Kammerlander et 
al, 2008).  Cutimed Sorbact dressings are coated with a fatty acid derivative 
DACC (dialkyl carbamoyl chloride), providing the product with strong hydrophobic 
properties.  Wound pathogens also have hydrophobic characteristics, therefore 
they become irreversibly bound to the fibres of the dressing in a moist wound 
environment. Cutimed Sorbact has no local antiseptic or antibiotic agent 
impregnated into the dressing.  This is a useful innovation as there is no donation 
of chemicals, which could lead to resistance or adverse side effects. This means 
the dressings can be safely used for longer than a 2 week period (Haycocks, 
2011).
Method
A Cutimed Sorbact evaluation was undertaken on two patients within the vascular 
clinic. The patients chosen for the evaluation were showing a lack of healing 
progression which was thought to be a result of high bacterial load.
Case Study One
Mr S underwent amputation of his right great, 2nd and 3rd toes due to diabetic 
neuro / ischaemia ulceration; at the time of amputation he had undergone 
successful revascularisation.  The majority of the wound healed well but the 
lower end of the wound dehisced leaving an open area of approximately 4 x 
3 cm which became sloughy. Within two weeks the slough was successfully 
debrided with the use of moist hydrofibre but then healing became static with 
a no evidence of advancing wound edges (Fig.1).  The wound bed was clean 
but had fragile granulation tissue and some malodour, therefore, it was thought 
that high bacterial load was hindering wound healing.  Topical silver dressings 
were used but with little effect.  He was seen in the Vascular Clinic 8 weeks post 
amputation and was commenced on Cutimed Sorbact with the aim of reducing 
the bacterial load and promoting healing.
Results
After using Cutimed Sorbact for only 2 weeks, the bacterial load appeared to be 
reducing and the wound edges started to advance, after 6 weeks use the wound 
had almost completely healed (Fig.2).
Case Study Two
Mrs T underwent left forefoot amputation due to a severe diabetic foot infection. 
Magnetic Resource Angiograms were undertaken and showed that there was no 
significant evidence of peripheral arterial disease. The wound dehisced on the 
lateral edge on removal of sutures.  In clinic 10 weeks post amputation there was 
evidence of superficial slough and the wound had moderate levels of exudate 
which had a significant malodour; the wound edges appeared static.  The wound 
had been previously dressed with cadexomer iodine paste which did not appear 
to be controlling the bacterial level to allow healing to occur; therefore Cutimed 
Sorbact was commenced (Fig.3).
Results
Within 2 weeks of commencing Cutimed Sorbact there was evidence of 
improvement on the wound bed and at review 6 weeks later total healing had 
occurred (Fig.4).
Conclusion
Cutimed Sorbact was found to be an effective treatment for the management 
of wounds showing signs of delayed healing due to increased bacterial load. 
In these case studies Cutimed Sorbact was found to be effective where other 
antimicrobial dressings failed to have an impact on wound healing.  Furthermore, 
often high risk or hard to heal patients require longer antimicrobial therapy than 
the currently recommended 2 weeks duration (Wounds UK, 2010). Due to the 
fact that Cutimed Sorbact dressings do not donate any chemicals into the wound 
bed it could therefore be a useful tool for those wounds that require longer 
antimicrobial therapy.
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